[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.41.181. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Article
August 1974

Altered Endogenous Fibrinolysis and Biochemical Factors in Atherosclerosis

Author Affiliations

From the Veterans Administration Hospital (Drs. Peabody, Tsapogas, Wu, Deveraj, and Karmody) and the Albany Medical College (Drs. Peabody, Tsapogas, Wu, Karmody, and Eckert), Albany, NY. Dr. Tsapogas is now with Ellis Hospital, Schenectady, NY.

Arch Surg. 1974;109(2):309-313. doi:10.1001/archsurg.1974.01360020169033
Abstract

Biochemical and fibrinolytic factors that may affect atherogenesis were evaluated in 1,077 subjects. Eight hundred thirty-six (78%) of them, of mean age 60.1 years, were found free of symptoms of atherosclerosis, while 241 (22%) of mean age 63.7 years, had definite signs and symptoms of atherosclerosis.

There was a significant depression of the fibrinolytic activity in the atherosclerotic group, and fibrinogen, glucose, cholesterol, and triglyceride levels were also increased. An age-matched comparison was carried out to eliminate the effect of difference between the two groups. The changes in the tested parameters remained significant, but, in addition, coagulation as measured by the activated partial thromboplastin time was significantly prolonged in the age-matched atherosclerotic group.

The results suggest that depressed endogenous fibrinolytic activity and other biochemical changes may be factors in atherogenesis.

References
1.
Nolf P:  Contribution a l'etude de la coagulation du sang . Arch Int Physiol Biochim 6:306-359, 1908.
2.
Astrup T:  Role of blood coagulation and fibrinolysis in the pathogenesis of arteriosclerosis , in The Heart and Circulation: Second National Conference on Cardiovascular Diseases . Washington, DC, Federation of American Societies for Experimental Biology, 1965, vol 1.
3.
Duguid JB:  Thrombosis as a factor in pathogenesis of coronary atherosclerosis . J Pathol Bacteriol 58:207-212, 1946.Article
4.
Lackner H, Johnson AJ:  The fibrinolytic system in South African white and Bantu men . Thromb Diath Haemorrh 18:456-461, 1967.
5.
Sevitt S:  The boundaries between physiology, pathology and irreversibility after surgery . Lancet 2:1203-1210, 1966.Article
6.
Nestel PJ:  Fibrinolytic activity of the blood in intermittent claudication . Lancet 2:373-374, 1959.Article
7.
Naimi S:  Studies of coagulation and fibrinolysis of the arterial and venous blood in normal subjects and patients with atherosclerosis . Circulation 27:904-918, 1963.Article
8.
Tsapogas MJ:  The role of fibrinolysis in treatment of arterial thrombosis . Ann R Coll Surg Engl 34:293-313, 1964.
9.
Hilleboe HE, James G, Doyle JT:  Cardiovascular health center. Project design for public health research . Am J Pub Health 44:851-863, 1954.
10.
 New weight standards for men and women , in Statistical Bulletin . New York, Metropolitan Life Insurance Co, 1959, vol 40.
11.
Phillips RE: The Fiuorometric Determination of Serum Triglycerides . Palo Alto, Calif, GK Turner Assoc Inc, 1969.
12.
Fearnley GF, Balmforth G, Fearnley E:  Evidence of a diurnal fibrinolytic rhythm, with a simple method of measuring natural fibrinolysis . Clin Sci 16:645-650, 1957.
13.
Ratnoff O, Menzie C:  New method for determination of fibrinogen in small samples of plasma . J Lab Clin Med 37:316-320, 1951.
14.
Johnson AJ, Kline DL, Alkjaersig N:  Assay methods and standard preparations for plasmin, plasminogen and urokinase in purified systems . Thromb Diath Haemorrh 21:259-272, 1969.
15.
Spector I, Corn M:  Control of heparin therapy with activated thromboplastin times . JAMA 201:157-159, 1967.Article
16.
Blix S:  Studies on the fibrinolytic system in the euglobulin fraction of human plasma . Scand J Clin Lab Invest 13( (suppl 58) ):3-19, 1961.
17.
Ygge J:  Studies on blood coagulation and fibrinolysis in conditions associated with an increased incidence of thrombosis . Scand J Haematol , (suppl 11) , pp 18-20, 1970.
18.
Nilsson IM, Olow B:  Fibrinolysis induced by streptokinase in man . Acta Chir Scand 123:247-266, 1962.
19.
Dixon WJ, Massey FJ:  Analysis of variance , in Introduction to Statistical Analysis , ed 3. New York, McGraw-Hill Book Co, Inc, 1969, chap 10.
20.
Frederickson DS:  Atherosclerosis and other forms of arteriosclerosis , in Wintrobe MM, et al (eds): Harrison's Principles of Internal Medicine . New York, McGraw-Hill Book Co Inc, 1974, (pt 8) , sect 2.
21.
Astrup T, Thorsen S:  The physiology of fibrinolysis . Med Clin North Am 56:153-162, 1972.
22.
Astrup T, Cocchieri S:  Thromboplastic and fibrinolytic activity of atherosclerotic human aorta . Nature 193:182-183, 1962.Article
23.
Constantini R, et al:  Plasminogen activator content of the arterial wall in occlusive arterial diseases . Thromb Diath Haemorrh 27:649-653, 1972.
24.
Spottl F, et al:  A basic study on the global coagulation and fibrinolysis of hyperlipemic and atherosclerotic patients: II. Plasminogen activator, plasminogen, α2-macroglobulin in atherosclerosis and endogenous hypertriglyceridemia . Atherosclerosis 12:427-437, 1970.Article
25.
Korsan-Bengtsen K, Wilhelmsen L, Tibblin G:  Blood coagulation and fibrinolysis in a random sample of 788 men 54 years old: I. Correlations between the variables of clotting and fibrinolysis . Thromb Diath Haemorrh 28:89-98, 1972.
26.
O'Brien ET:  The fibrinolytic system in atherosclerosis . J Ir Med Assoc 62:203-212, 1969.
27.
Korsan-Bengtsen K, Wilhelmson L, Tibblin G:  Blood coagulation and fibrinolysis in a random sample of 788 men 54 years old: II. Relations of the variables to "risk factors" for myocardial infarction . Thromb Diath Haemorrh 28:99-108, 1972.
28.
Grieg HBW:  Inhibition of fribrinolysis by alimentary lipemia . Lancet 2:16-18, 1956.Article
29.
Howell M:  Effects of plasma lipids on fibrinolysis . Br Med Bull 20:200-204, 1964.
30.
Dubber A, et al:  The effect of fat feeding on fibrinolysis "Stypven time" and platelet aggregation . J Atheroscl Res 7:225-235, 1967.Article
31.
Ogston D, Fullerton HW:  Effects of alimentary lipemia on plasma fibrinolytic activity . Br Med J 1288-1290, 1962.
32.
Walker AR:  Fibrinolytic activity of whole blood from South African Bantu and white subjects . Am J Clin Nutr 9:461-472, 1961.
33.
Chopin SF, Beard EL:  In vitro effects of lipids on fibrinolysis . Thromb Diath Haemorrh 29:286-292, 1973.
34.
Fearnley GR, Chakrabarti R, Avis PR:  Blood fibrinolytic activity in diabetes mellitus and its bearing on ischemic heart disease and obesity . Br Med J 1:921-923, 1963.Article
35.
Tsapogas MJ, et al:  Depressed endogenous fibrinolytic activity in essential hypertension , in Abstracts of the International Cardiovascular Society Meeting, Barcelona, Spain, Sept 27-29, 1973 . Milan, Minerva Medical, p 146.
36.
Fearnley GR: Fibrinolysis . Baltimore, Williams & Wilkins Co, 1965, p 61.
37.
Bennett NB, Ogston CM, Ogston D:  Studies on the blood fibrinolytic enzyme system following acute myocardial infarction . Clin Sci 32:27-37, 1967.
38.
Basu HN, et al:  Study of plasma fibrinogen and fibrinolytic activity in acute myocardial infarction . J Ind Med Assoc 57:135-138, 1971.
39.
Sikka HK, et al:  Blood coagulation and fibrinolysis in relation to coronary artery disease . Ind J Med Res 56:411-415, 1968.
40.
Fearnley GR, Chakrabarti R, Hocking ED:  Fibrinolytic effects of diguanides plus ethylestrenol in occlusive vascular disease . Lancet 2:1008-1011, 1967.Article
41.
Davidson JF, et al:  Fibrinolytic enhancement by stanozolol: A double blind trial . Br J Haematol 22:543-559, 1972.Article
×